Yanbin Chen
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Breast Cancer Treatment Studies
Papers in
-
- Cancer-related molecular mechanisms research 8
- MicroRNA in disease regulation 4
- Cancer, Hypoxia, and Metabolism 3
Yanbin Chen
33 papers receiving 570 citations
Peers
Comparison fields: 5 of 85
- Cancer Research 161
- Applied Microbiology and Biotechnology 17
- Oncology 125
- Immunology 94
- Molecular Medicine 21
Countries citing papers authored by Yanbin Chen
This map shows the geographic impact of Yanbin Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanbin Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanbin Chen more than expected).
Fields of papers citing papers by Yanbin Chen
This network shows the impact of papers produced by Yanbin Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanbin Chen. The network helps show where Yanbin Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yanbin Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 28 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 12 | |
| 6 | 2022 | 18 | |
| 7 | 2022 | 0 | |
| 8 | 2021 | 21 | |
| 9 | 2021 | 1 | |
| 10 | 2020 | 42 | |
| 11 | 2020 | 27 | |
| 12 | 2019 | 53 | |
| 13 | 2017 | 45 | |
| 14 | 2017 | 41 | |
| 15 | 2017 | 35 | |
| 16 | [Knockdown of myeloid cell leukemia 1 gene inhibits the proliferation and promotes apoptosis of prostate cancer cells]. | 2017 | 0 |
| 17 | 2015 | 24 | |
| 18 | 2015 | 11 | |
| 19 | 2014 | 8 | |
| 20 | 2011 | 2 |
About Yanbin Chen
Yanbin Chen is a scholar working on Cancer Research, Applied Microbiology and Biotechnology, Molecular Medicine, Oncology and Molecular Biology, having authored 35 papers that have together received 578 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (5 papers), MicroRNA in disease regulation (4 papers), Peptidase Inhibition and Analysis (4 papers), Ferroptosis and cancer prognosis (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Immune cells in cancer (3 papers) and Circular RNAs in diseases (3 papers). The work is most often cited by research in Cancer Research (161 citations), Applied Microbiology and Biotechnology (17 citations), Oncology (125 citations), Immunology (94 citations) and Molecular Medicine (21 citations). Yanbin Chen has collaborated with scholars based in China, Taiwan and Pakistan. Frequent co-authors include Pibao Li, Tingting Zuo, Jie Gu, Jianguang Wang, Dechun Liu, Like Zhang, Qingqing Su, Miao Deng, Sheng Chen and Lijie Yang. Their work appears in journals such as Scientific Reports, Phytotherapy Research, Journal of Cellular Physiology, Frontiers in Immunology and Innate Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.